AJU IB Investment Co., Ltd.
Follow13F filer, CIK 1710065, Seoul, Korea Republic of
AJU IB Investment Co., Ltd. reported $102,752,693 across 8 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-04-08.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-25-012673
- Period
- 2024-12-31
- Reported value
- $103M
- Holdings
- 8
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001140361-25-012673, largest first. % of portfolio is the value over $102,752,693, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ACLXARCELLX INC | 1,047,557 | $80.3M | 78.18% | Timeline | |||
| KYMRKYMERA THERAPEUTICS INC | 457,059 | $18.4M | 17.89% | Timeline | |||
| SEERSEER INC | 816,375 | $1.89M | 1.84% | Timeline | |||
| RALLYBIO CORPRALLYBIO CORP | 754,678 | $724K | 0.71% | ||||
| XLOXilio Therapeutics Inc. | 667,742 | $638K | 0.62% | Timeline | |||
| SUTRO BIOPHARMA INCSUTRO BIOPHARMA INC | 175,000 | $322K | 0.31% | ||||
| CARMCARISMA THERAPEUTICS INC COM | 718,332 | $301K | 0.29% | Timeline | |||
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 99,503 | $157K | 0.15% |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001140361-25-012673 | base | 2025-04-08 | acceptance time not in the bulk data set |